Company Presentation – Australian non deal roadshow
We are pleased to announce that Brent Barnes, CEO and Managing Director will be leading a non-deal roadshow in Australia this week. Mr Barnes and Ray Ridge, CFO, will be attending meetings with existing and new institutional investors as well as brokers and research analysts in Sydney, Melbourne and Adelaide. Click here to view the presentation
Financial Report - Year ended 30 June 2018
Today we released our financial report for year ending 30 June 2018.
Finalisation of South Australian Government Loan Facility Agreement
The Company announced the $4 million Facility on 19 February 2018, subject to formal legal documentation. The
documentation, comprising a Loan Facility Agreement and a Security Deed, have now been fully executed and the conditions
to enable the first drawdown have been met.
First commercial sale of APAS Independence
We are extremely pleased to announce the first commercial sale of the APAS Independence to St Vincent’s Hospital in Melbourne. Click the link below for the announcement that was made to the ASX.
Company OverviewOver the past decade, LBT Innovations has emerged as a groundbreaking designer of advanced automated solutions for the preparation and analysis of microbiology culture specimens, with significant benefi...
MicroStreakIn its first five years of global sales, LBT’s MicroStreak technology captured the largest share of the international market for automated culture-plate streaking and inoculation. Originally sold by bi...
APASThe Automated Plate Assessment System, or APAS, is a platform technology for the automation of culture-plate screening and interpretation. While LBT’s first product, PREVI Isola, automates the inoculati...